Captopril-impaired production of tumor necrosis factor-α-induced interleukin-1β in human monocytes is associated with altered intracellular distribution of nuclear factor-κB

Journal of Laboratory and Clinical Medicine

Volumn 140, Issue 2, 2002, Pages 103-109

  Andersson, Patrik ^a,b,c   Cederholm, Tommy ^a,b,c   Johansson, Anne Sofie ^a,b,c   Palmblad, Jan ^a,b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0036672288     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2002.125905     Document Type: Article

References (40)

1. The effects of ACE inhibitors and other antihypertensive drugs on cardiovascular risk factors and atherogenesis
2. Beneficial effect of captopril in acute coxsackievirus B3 murine myocarditis
3. Captopril: A new treatment for rheumatoid arthritis?
4. Effect of high-versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure
5. Angiotensin converting enzyme inhibitors suppress synthesis of tumor necrosis factor and interleukin-1 by human peripheral blood mononuclear cells
6. Angiotensin converting enzyme inhibitors suppress production of tumor necrosis factor in vitro and in vivo
7. The effect of renin-angiotensin system inhibitors on pro-and anti-inflammatory cytokine production
8. Structure and mechanism of interleukin-1β converting enzyme
9. NF-β activation
10. Enhanced generation of interleukins-1β beta and 6 may contribute to the cachexia of chronic disease
11. Rapid detection of octamer binding proteins with mini-extracts prepared from a small number of cells
12. Marked heterogeneity in protein levels and functional integrity of the thrombopoietin receptor c-mpl in polycythaemia vera
13. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I βα alpha: A mechanism for NF-κB activation
14. Suppression of tumor necrosis factor-activated nuclear transcription factor-β, activator protein-1, c-jun N-terminal kinase and apoptosis by beta-lapachone
15. Identification of a monocyte specific pre interleukin-1β convertase activity
16. Phosphorylation meets ubiquitination: The control of NF-κB activity
17. The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation
18. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity
19. Vesnarinone suppress TNF-induced activation of NF-kappa B, c-jun kinase and apoptosis
20. Effect of cyclosporin A on inflammatory cytokine production by U937 monocyte-like cells
21. Nicotine inhibits the production of inflammatory mediators in U937 cells through modulation of nuclear factor-kappaB activation
22. Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-kappa B activation
23. Differences in the synthesis and kinetics of release of interleukin 1 alpha, interleukin 1 beta and tumor necrosis factor from human mononuclear cells
24. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
25. Tumor necrosis factor alpha serum activity during treatment of acute decompensation of cachectic and non-cachectic patients with advanced congestive heart failure
26. Captopril inhibits the production of tumor necrosis factor-alpha by human mononuclear cells in patients with congestive heart failure
27. Increased concentration of tumor necrosis factor in "cachectic" patients with severe chronic heart failure
28. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia
29. The relationship of the erythrocyte sedimentation rate to inflammatory cytokines and survival in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors
30. Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function
31. Cardiodepression by tumor necrosis factor alpha
32. The endotoxin-lipoprotein hypothesis
33. Elevated soluble CD 14 receptors and altered cytokines in chronic heart failure
34. Remission of nephrotic syndrome in type 1 diabetes: Long-term follow-up of patients in the Captopril Study
35. Strong association between malnutrition, inflammation and atherosclerosis in chronic renal failure
36. Do ACE-inhibitors suppress tumor necrosis factor-alpha production in advanced chronic renal failure?
37. Positron-labeled angiotensin-converting enzyme (ACE) inhibitor: Fluorine-18-fluorocaptopril. Probing the ACE activity in vivo by positron emission tomography
38. Reactive oxygen species and vascular cell apoptosis in response to angiotensin II and pro-atherosclerotic factors
39. Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells
40. Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure